Changes in MDA5 and TLR3 Sensing of the Same Diabetogenic Virus Result in Different Autoimmune Disease Outcomes

Area of Science:

• Immunology
• Virology
• Endocrinology

Background:

• Melanoma differentiation-associated protein 5 (MDA5) and toll-like receptor-3 (TLR3) are key sensors of RNA viruses, inducing type I interferon (IFN-I).
• Despite sensing similar targets, their distinct roles in disease pathogenesis remain incompletely understood.

Purpose of the Study:

• To investigate how differential sensing of coxsackievirus by MDA5 and TLR3 influences type I interferon signatures and autoimmune diabetes development.
• To elucidate the role of localized interferonopathy in T cell regulation and type 1 diabetes (T1D) onset.

Main Methods:

• Utilized a diabetogenic islet β cell-tropic coxsackievirus strain (CB4) in NOD mice.
• Manipulated MDA5 and TLR3 signaling pathways to assess their impact on IFN-I induction and disease outcomes.
• Analyzed IFN-α and IFN-β signatures and T cell regulatory responses.

Main Results:

• Reduced MDA5 signaling conferred protection against coxsackievirus-induced diabetes, whereas reduced TLR3 function maintained diabetes susceptibility.
• Differential sensing by MDA5 and TLR3 generated distinct IFN-α and IFN-β profiles, correlating with varying disease outcomes.
• Localized induction of IFN-I at the infection site led to interferonopathy, T cell dysregulation, and autoimmune diabetes.

Conclusions:

• The balance of MDA5 and TLR3 signaling critically determines type I interferon responses and subsequent autoimmune diabetes development.
• Targeting IFN-I induction at the site of viral infection offers a potential strategy for preventing T1D in susceptible models.
• This study provides evidence for controlling IFN-I to modulate responses from viral clearance to autoimmune disease onset.